ArticleThe journal of nutrition, health & aging2026
Association of dietary copper intake with Alzheimer's disease, brain structure and cognitive function.
Article in The journal of nutrition, health & aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to investigate the relationships between dietary copper intake and the risk of Alzheimer's disease (AD), cognitive function, and brain structural measures.
designA combined prospective cohort and cross-sectional analysis.
settingThe UK Biobank.
participantsThis analysis included 126,660 participants (56,053 males and 70,607 females) from the UK Biobank who were free of baseline dementia and had complete dietary data. The mean age at baseline was 56.14 ± 7.83 years, and the median dietary copper intake was 1.33 mg/day (IQR: 1.10-1.61). MEASUREMENTS: Dietary copper intake was assessed via 24-h dietary recalls. AD diagnosis was obtained from health records. Cognitive function and brain structural measures were derived from neuropsychological assessments and MRI scans, respectively. Cox proportional hazards models with restricted cubic splines were used to examine associations.
resultsOver a median follow-up of 13.34 years, 619 participants developed AD. A nonlinear U-shaped association was observed between copper intake and AD risk (P for nonlinearity <0.001), with the lowest risk at an intake of 1.57 mg/day. Compared to the reference intake (1-2 mg/day), both lower and higher intakes were associated with increased AD risk, with the highest risk at intakes ≥3 mg/day (HR = 2.73, 95% CI: 1.53-4.87). This pattern remained consistent across subgroups stratified by genetic risk. Copper intake also showed significant nonlinear associations with cognitive function and brain structure, with optimal ranges consistently observed between approximately 1.3 and 2.0 mg/day.
conclusionDietary copper intake exhibits a U-shaped association with AD risk, and maintaining intake within an appropriate range (approximately 1.3-2.0 mg/day) may help reduce AD risk and benefit cognitive function and brain health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.